Erratum: Author’s Affiliation Correction. Type II human epidermal growth factor receptor heterogeneity is a poor prognosticator for type II human epidermal growth factor receptor positive gastric cancer (World J Clin Cases 2019; Aug 6; 7 (15): 1964-1977)

Correction to " Type II human epidermal growth factor receptor heterogeneity is a poor prognosticator for type II human epidermal growth factor receptor-positive gastric cancer" World J Clin Cases 2019; 7(15): 1964-1977. In this article, one of the affiliation of the first author was lacke...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaito, Akio, Kuwata, Takeshi, Tokunaga, Masanori, Shitara, Kohei, Sato, Reo, Akimoto, Tetsuo, Kinoshita, Takahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674736/
https://www.ncbi.nlm.nih.gov/pubmed/33269289
http://dx.doi.org/10.12998/wjcc.v8.i21.5494
_version_ 1783611569143283712
author Kaito, Akio
Kuwata, Takeshi
Tokunaga, Masanori
Shitara, Kohei
Sato, Reo
Akimoto, Tetsuo
Kinoshita, Takahiro
author_facet Kaito, Akio
Kuwata, Takeshi
Tokunaga, Masanori
Shitara, Kohei
Sato, Reo
Akimoto, Tetsuo
Kinoshita, Takahiro
author_sort Kaito, Akio
collection PubMed
description Correction to " Type II human epidermal growth factor receptor heterogeneity is a poor prognosticator for type II human epidermal growth factor receptor-positive gastric cancer" World J Clin Cases 2019; 7(15): 1964-1977. In this article, one of the affiliation of the first author was lacked. Akio Kaito, the first author, belonged to Course of Advanced Clinical Research of Cancer, Juntendo University Graduate School of Medicine, Tokyo 163-8001, Japan.
format Online
Article
Text
id pubmed-7674736
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-76747362020-12-01 Erratum: Author’s Affiliation Correction. Type II human epidermal growth factor receptor heterogeneity is a poor prognosticator for type II human epidermal growth factor receptor positive gastric cancer (World J Clin Cases 2019; Aug 6; 7 (15): 1964-1977) Kaito, Akio Kuwata, Takeshi Tokunaga, Masanori Shitara, Kohei Sato, Reo Akimoto, Tetsuo Kinoshita, Takahiro World J Clin Cases Correction Correction to " Type II human epidermal growth factor receptor heterogeneity is a poor prognosticator for type II human epidermal growth factor receptor-positive gastric cancer" World J Clin Cases 2019; 7(15): 1964-1977. In this article, one of the affiliation of the first author was lacked. Akio Kaito, the first author, belonged to Course of Advanced Clinical Research of Cancer, Juntendo University Graduate School of Medicine, Tokyo 163-8001, Japan. Baishideng Publishing Group Inc 2020-11-06 2020-11-06 /pmc/articles/PMC7674736/ /pubmed/33269289 http://dx.doi.org/10.12998/wjcc.v8.i21.5494 Text en ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Correction
Kaito, Akio
Kuwata, Takeshi
Tokunaga, Masanori
Shitara, Kohei
Sato, Reo
Akimoto, Tetsuo
Kinoshita, Takahiro
Erratum: Author’s Affiliation Correction. Type II human epidermal growth factor receptor heterogeneity is a poor prognosticator for type II human epidermal growth factor receptor positive gastric cancer (World J Clin Cases 2019; Aug 6; 7 (15): 1964-1977)
title Erratum: Author’s Affiliation Correction. Type II human epidermal growth factor receptor heterogeneity is a poor prognosticator for type II human epidermal growth factor receptor positive gastric cancer (World J Clin Cases 2019; Aug 6; 7 (15): 1964-1977)
title_full Erratum: Author’s Affiliation Correction. Type II human epidermal growth factor receptor heterogeneity is a poor prognosticator for type II human epidermal growth factor receptor positive gastric cancer (World J Clin Cases 2019; Aug 6; 7 (15): 1964-1977)
title_fullStr Erratum: Author’s Affiliation Correction. Type II human epidermal growth factor receptor heterogeneity is a poor prognosticator for type II human epidermal growth factor receptor positive gastric cancer (World J Clin Cases 2019; Aug 6; 7 (15): 1964-1977)
title_full_unstemmed Erratum: Author’s Affiliation Correction. Type II human epidermal growth factor receptor heterogeneity is a poor prognosticator for type II human epidermal growth factor receptor positive gastric cancer (World J Clin Cases 2019; Aug 6; 7 (15): 1964-1977)
title_short Erratum: Author’s Affiliation Correction. Type II human epidermal growth factor receptor heterogeneity is a poor prognosticator for type II human epidermal growth factor receptor positive gastric cancer (World J Clin Cases 2019; Aug 6; 7 (15): 1964-1977)
title_sort erratum: author’s affiliation correction. type ii human epidermal growth factor receptor heterogeneity is a poor prognosticator for type ii human epidermal growth factor receptor positive gastric cancer (world j clin cases 2019; aug 6; 7 (15): 1964-1977)
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674736/
https://www.ncbi.nlm.nih.gov/pubmed/33269289
http://dx.doi.org/10.12998/wjcc.v8.i21.5494
work_keys_str_mv AT kaitoakio erratumauthorsaffiliationcorrectiontypeiihumanepidermalgrowthfactorreceptorheterogeneityisapoorprognosticatorfortypeiihumanepidermalgrowthfactorreceptorpositivegastriccancerworldjclincases2019aug671519641977
AT kuwatatakeshi erratumauthorsaffiliationcorrectiontypeiihumanepidermalgrowthfactorreceptorheterogeneityisapoorprognosticatorfortypeiihumanepidermalgrowthfactorreceptorpositivegastriccancerworldjclincases2019aug671519641977
AT tokunagamasanori erratumauthorsaffiliationcorrectiontypeiihumanepidermalgrowthfactorreceptorheterogeneityisapoorprognosticatorfortypeiihumanepidermalgrowthfactorreceptorpositivegastriccancerworldjclincases2019aug671519641977
AT shitarakohei erratumauthorsaffiliationcorrectiontypeiihumanepidermalgrowthfactorreceptorheterogeneityisapoorprognosticatorfortypeiihumanepidermalgrowthfactorreceptorpositivegastriccancerworldjclincases2019aug671519641977
AT satoreo erratumauthorsaffiliationcorrectiontypeiihumanepidermalgrowthfactorreceptorheterogeneityisapoorprognosticatorfortypeiihumanepidermalgrowthfactorreceptorpositivegastriccancerworldjclincases2019aug671519641977
AT akimototetsuo erratumauthorsaffiliationcorrectiontypeiihumanepidermalgrowthfactorreceptorheterogeneityisapoorprognosticatorfortypeiihumanepidermalgrowthfactorreceptorpositivegastriccancerworldjclincases2019aug671519641977
AT kinoshitatakahiro erratumauthorsaffiliationcorrectiontypeiihumanepidermalgrowthfactorreceptorheterogeneityisapoorprognosticatorfortypeiihumanepidermalgrowthfactorreceptorpositivegastriccancerworldjclincases2019aug671519641977

Ejemplares similares